Leah Rosenbaum, Forbes Staff

Author's posts

BioNTech’s Humble Billionaire CEO On The Next Era Of MRNA Vaccines

Uğur Şahin, cofounder and CEO of BioNTech, became a billionaire thanks to his company’s success in creating one of the first Covid-19 vaccines. Here the scientist talks about what’s next.

BioNTech’s Humble Billionaire CEO On The Next Era Of MRNA Vaccines

Uğur Şahin, cofounder and CEO of BioNTech, became a billionaire thanks to his company’s success in creating one of the first Covid-19 vaccines. Here the scientist talks about what’s next.

30 Under 30 Europe 2021: Changing The World From Artificial Intelligence To Covid-19

These healthcare and science listmakers are inventing the future from the atom up.

What’s Next For Moderna Post-Covid-19: CEO Stephane Bancel Details mRNA Pipeline

One of the world’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine.

Europe’s Mixed Messages On AstraZeneca Vaccine Jeopardize Global Covid Response

The continent’s suspensions are eroding vaccine confidence just when the world needs it the most.

Moderna Starts Covid-19 Vaccine Trial In Kids Younger Than 12 Years Old

The clinical trials are being planned carefully due to ethical implications of testing vaccines in young children.

Novavax Says Vaccine Is 96% Effective At Preventing Original Covid-19 Virus

A press release issued by the company said the vaccine was 100% effective in preventing hospitalization and death for multiple variants

Congressional Subcommittee Launches Investigation Into One Medical’s Covid-19 Vaccine Distribution

The primary care company has been accused of knowingly giving vaccines to ineligible patients and prioritizing its own employees to receive scarce Covid-19 vaccines.

FDA Authorizes Johnson & Johnson’s Covid-19 Vaccine For Use In The U.S.

This is the third Covid-19 vaccine that has been granted Emergency Use Authorization by the FDA.

FDA Committee Votes Yes On Johnson & Johnson Covid-19 Vaccine; Authorization Could Follow Soon

The third Emergency Use Authorization for a Covid-19 vaccine could be days — or even hours– away.